Image For Activity Cover
Revolutionizing Single Shot Ablation: Affera™ Mapping System with Sphere-360™ Case Presentation and Discussion
Description
Join us for an exclusive first-in-human clinical experience with the groundbreaking Affera™ Sphere-360™ PFA Catheter.
Presentation
Revolutionizing Single Shot Ablation: Affera™ Mapping System with Sphere-360™ Case Presentation and Discussion
Presenter(s): Vivek Y. Reddy, MD

Revolutionizing Single Shot Ablation: Affera™ Mapping System with Sphere-360™ Case Presentation and Discussion
Presenter(s): Pierre Jais, MD

Revolutionizing Single Shot Ablation: Affera™ Mapping System with Sphere-360™ Case Presentation and Discussion
Presenter(s): Andreas Metzner

Revolutionizing Single Shot Ablation: Affera™ Mapping System with Sphere-360™ Case Presentation and Discussion
Presenter(s): Petr Peichl, MD, PhD

Disclosures
Vivek Reddy:
  • Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
  • Acutus Medical Inc (Stock Options – Publicly Traded - Consulting)
  • Affera, Inc. (Stocks – Privately Held - Consulting)
  • Aquaheart (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Autonomix (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Axon (Stock Options – Privately Held (including start-up companies) - Consulting)
  • BackBeat (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Biosig Technologies, Inc. (Stock Options – Publicly Traded - Consulting)
  • Circa Scientific (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Corvia Medical (Stock Options – Privately Held (including start-up companies) - Consulting)
  • EpiEP (Stocks – Privately Held - Consulting)
  • CardioNXT (Stocks – Privately Held - Consulting)
  • AFTX (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Farapulse (Stock Options – Privately Held (including start-up companies) - Consulting)
  • FIRE1 (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Luxcath (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Manual Surgical Sciences (Stocks – Privately Held - Consulting)
  • Medlumics (Stock Options – Privately Held (including start-up companies) - Consulting)
  • NewPace Ltd (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Surecor (Stock Options – Privately Held (including start-up companies) - Consulting)
  • VytronUS, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Valcare (Stock Options – Privately Held (including start-up companies) - Consulting)
  • CardiaCare (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Ablacon, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Dinova (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Kardium (Stock Options – Privately Held (including start-up companies) - Consulting)
  • HRT (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Intershunt (Stock Options – Privately Held (including start-up companies) - Consulting)
  • AtaCor Medical Inc (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Sirona Medical Technologies, Inc (Stock Options – Privately Held (including start-up companies) - Consulting)
  • CoreMap (Honoraria/Speaking/Consulting Fee - Consulting)
  • Corisma Inc (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Restore Medical (Stocks – Privately Held - Consulting)
  • VIZARAmed (Stocks – Privately Held - Consulting)
  • Anumana (Stock Options – Privately Held (including start-up companies) - Consulting)
  • APN Health (Stock Options – Privately Held (including start-up companies) - Consulting)
  • EP Frontiers (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Field Medical (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Focused Therapeutics (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Javelin (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Oracle Health (Stock Options – Privately Held (including start-up companies) - Consulting)
  • Soundcath (Stocks – Privately Held - Consulting)
  • Abbott Medical (Honoraria/Speaking/Consulting Fee - Consulting)
  • Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
  • Atrian Medical Ltd. (Honoraria/Speaking/Consulting Fee - Consulting)
  • BioTel (Honoraria/Speaking/Consulting Fee - Consulting)
  • Biotronik (Honoraria/Speaking/Consulting Fee - Consulting)
  • Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
  • Cairdac (Honoraria/Speaking/Consulting Fee - Consulting)
  • CardioFocus, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
  • W.L. Gore & Associates (Honoraria/Speaking/Consulting Fee - Consulting)
  • Impulse Dynamics USA (Honoraria/Speaking/Consulting Fee - Consulting)
  • Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
  • Novo Nordisk (Honoraria/Speaking/Consulting Fee - Consulting)
  • Novartis (Honoraria/Speaking/Consulting Fee - Consulting)
  • Philips (Honoraria/Speaking/Consulting Fee - Consulting)
  • Pulse Biosciences (Honoraria/Speaking/Consulting Fee - Consulting)
  • Nyra Medical (Stocks – Privately Held - Consulting)
  • DRS Vascular (Stocks – Privately Held - Consulting)
Pierre Jais:
  • inHEART (Ownership/Partnership/Principal - Consulting)
  • Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
  • Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
  • Medtronic (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Andreas Metzner:
  • Nothing Relevant to Disclose
Petr Peichl:
  • Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
  • Biotronik (Honoraria/Speaking/Consulting Fee - Consulting)
  • Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
  • Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
  • Medtronic (Honoraria/Speaking/Consulting Fee - Consulting)

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.
Summary
Availability: No future session
Cost: FREE
Credit Offered:
No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Cookie Declaration | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Android App Download IOS App Download Powered By